VOXEA The Clinical Voice AI Infrastructure for Healthcare VOXEA is turning voice into the next generation of scalable, reimbursable biomarkers for some of healthcare’s highest-cost diseases — including depression, heart failure, hypertension, Alzheimer’s, COPD, and lung cancer. Its core asset is a clinical-grade acoustic biomarker foundation model with 1.8B parameters — one of the first voice AI systems to achieve regulatory-grade clinical validation and medical device approval. VOXEA is building the infrastructure and data moat required to scale voice AI across healthcare through multimodal clinical data, telehealth deployment, real-world evidence, and reimbursement integration. The company’s vision is to make voice a reimbursable digital vital sign within the next five years — powering the future of healthcare AI.
| Website | https://voxea.tech/ |
| Employees | 4 (1 on RocketReach) |
| Industry | Technology, Information and Internet |
Looking for a particular VOXEA employee's phone or email?
VOXEA Questions
Wendy Wu is the Founder of VOXEA.
1 people are employed at VOXEA.
Top VOXEA Employees
-
Wendy Wu
Founder at VOXEA
United States1
